Sarepta Therapeutics SRPT
NASDAQ SRPT
$17.57 -0.65 (-3.57%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Accumulated Expenses (2013 - 2026)

Updated

Sarepta Therapeutics' Accumulated Expenses was $325.23 million in Q2 2026, down 13.8% from $377.4 million a year earlier but up 7.6% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Accumulated Expenses (2013 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Sarepta Therapeutics came in at $359.66 million, down 3.7% from FY2024.

  • Accumulated Expenses shows a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
  • In earlier years, Accumulated Expenses was $373.51 million in FY2024 (+18.6%), $315 million in FY2023 (-24.8%), $419 million in FY2022 (+54.2%) and $271.7 million in FY2021 (+40.4%).
  • Quarterly Accumulated Expenses has moved between $221.01 million (Q3 2021) and $419 million (Q4 2022) over five years.
  • Compared with a year earlier, Accumulated Expenses has declined for four straight quarters, with growth averaging 2.1% over the last eight quarters.
  • The best year-over-year quarter for Accumulated Expenses over five years was Q3 2022 (growth of 67.0%); the worst was Q4 2023 (a decline of 24.8%).
  • Per Business Quant data, SRPT's Accumulated Expenses in the three quarters before Q2 2026 was $302.37 million (Q1 2026), $359.66 million (Q4 2025) and $295.79 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Sarepta Therapeutics 1.92 Bn -1.31 Bn 251.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 325.23 Mn
Mar 31, 2026 302.37 Mn
Dec 31, 2025 359.66 Mn
Sep 30, 2025 295.79 Mn
Jun 30, 2025 377.40 Mn
Mar 31, 2025 391.65 Mn
Dec 31, 2024 373.51 Mn
Sep 30, 2024 344.83 Mn
Jun 30, 2024 350.40 Mn
Mar 31, 2024 283.32 Mn
Dec 31, 2023 315.00 Mn
Sep 30, 2023 322.35 Mn
Jun 30, 2023 326.88 Mn
Mar 31, 2023 345.55 Mn
Dec 31, 2022 419.00 Mn
Sep 30, 2022 369.00 Mn
Jun 30, 2022 383.70 Mn
Mar 31, 2022 293.91 Mn
Dec 31, 2021 271.70 Mn
Sep 30, 2021 221.01 Mn
API Access

Sarepta Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SRPT&period=max&api_key=YOUR_API_KEY